Industry

non-CME

Natera Industry Session: Know Cancer’s Next Move: How Personalized ctDNA testing Can Help Guide Perioperative Decision Making

Faculty(s)

• 

  Michael Krainock, MD, PhD

  Medical Director, Oncology
  Natera, Inc.

  Disclosure information not submitted.